Home Sitemap Contact us Accessibility Statement Top of the page

Pain in focus

We offer a comprehensive range of pain management solutions that enable you to respond effectively to the individual requirements of each patient.

Pain for healthcare professionalsWe focus on supporting the NHS in managing conditions like chronic pain. Our aim is to work in partnership to develop joined-up care through Joint Working projects, to improve patient outcomes and enhance patient experience, and also to offer value for money. That might be through medicines optimisation, quality improvement, pathway redesign or improvement, innovation or identifying cost efficiencies.

At least eight million people in the UK suffer with chronic pain,1 resulting in a major impact on their quality of life and inability to maintain regular work.

Most patients with chronic pain can be well managed in the community or local hospitals by appropriately trained members of interdisciplinary Pain Management Services; however, some patients with more complex chronic pain problems require management in highly specialised Pain Management centres.

Breakthrough pain is common in cancer patients

Breakthrough cancer pain affects cancer patients who already experience controlled every day pain. It comes on suddenly and quickly, often without warning, it is usually short-lived – typically lasting about 30-60 minutes, although the episodes can vary. 

Oncology nurses have an important role in identifying and managing breakthrough cancer pain and in referring difficult cases to Pain Specialists.

Effentora® (fentanyl buccal tablet)

Actiq® (oral transmucosal fentanyl citrate)

Axsain® (capsaicin cream 0.075%)

Zacin® (capsaicin cream 0.025%)

Further support for healthcare professionals

Further support for healthcare professionals
  • For factual, scientific-based information about Effentora®, Actiq®, Axsain® and Zacin®, contact Teva’s Medical Information Service via e-mail medinfo@tevauk.com or call 0207 540 7117
  • Further information, including Prescribing Information for Effentora®, Actiq®, Axsain® and Zacin® is available from the respective pages
  • You can also request a visit from the Key Account Manager here

Joint Working

Joint Working

Our Joint Working projects help the NHS and healthcare professionals deliver improved patient outcomes. Our Joint Working projects are available on our Joint Working pages.

To discuss potential Joint Working opportunities with Teva within Pain Management you can contact us and a representative from Teva will be in touch.

1 https://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-d/d08/ [accessed 19.04.16].

2 Effentora® (fentanyl buccal tablet) Summary of Product Characteristics.

3 Actiq® (oral transmucosal fentanyl citrate) Summary of Product Characteristics.

4 Axsain® (capsaicin cream 0.075%) Summary of Product Characteristics.

5 Zacin® (capsaicin cream 0.025%) Summary of Product Characteristics.

Teva UK Limited

Are you a healthcare professional?

To access this section of the Teva UK Limited website you need to be a member of the healthcare profession because the materials included in this area of our website are specifically prepared for that audience only.
To understand why that is - please visit: Working in a regulated environment

Please click on the appropriate button below to confirm that you are healthcare professional.
If you are not a healthcare professional, you will be taken to an area of the website that is appropriate for you.

I am a